Oswaldo Bisbal, MD
Gastroenterology · Lewiston, MENPI 1487686242
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Boston Scientific at 50.4% of the total. Reporting peaked in 2022 at $1,210 and has fallen 83.8% since, to $196 in 2025.
Across 84 payments — averaging $28.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- AbbVie$480
- Takeda Pharmaceuticals U.S.A., Inc.$223
- Gilead$120
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$70
- Johnson & Johnson$64
- plus $235 from 8 others
What the payments were for
- Travel & lodging$1,16048%
- Food & beverage$1,24252%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $1,210 |
| AbbVie(2 entities) | 33 | $480 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $223 |
| Gilead | 8 | $120 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $70 |
| Johnson & Johnson | 5 | $64 |
| QOL Medical, LLC | 5 | $64 |
| Pfizer | 4 | $59 |
| Braintree Laboratories, Inc. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Merck | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORISE$1,160
How this compares
$2,402 in reported general payments places this provider in the 70th percentile of 68 gastroenterology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 155 | $9,999 |
| Budesonide DrBudesonide | 15 | $4,908 |
| Mesalamine | 16 | $4,080 |
| Ursodiol | 16 | $3,455 |
| Ondansetron OdtOndansetron | 232 | $1,937 |
| Sucralfate | 49 | $1,299 |
| Omeprazole | 83 | $914 |
| Pantoprazole Sodium | 26 | $360 |
| Esomeprazole Magnesium | 11 | $341 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 18 | $283 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 14 | $198 |
| Famotidine | 12 | $115 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Lewiston
- Winoah HenryLewiston$13K
- Benjamin SteinLewiston$4K
- Emil MiskovskyLewiston$2K
- John MladuckyLewiston$2K
- John LewandowskiLewiston$250
- Catherine McCrannLewiston$146
- Douglas HowellPortland$1.2M
- Martin MoehlenPortland$340K
- Tahira SaifuddinBangor$84K
- Brian BerberianBangor$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.